Overweight and Obesity: Epidemiology Report and Forecast to 2035
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Analyze overweight and obesity epidemiology across the seven major markets with 10-year forecasts for diagnosed and total prevalent cases by age, sex, BMI class, and comorbidities.
Why Does Overweight and Obesity Epidemiology Matter?
Overweight and obesity are major health conditions associated with excess body fat, metabolic dysfunction, chronic inflammation, and comorbidities including diabetes and cardiovascular disease. Understanding the size and characteristics of these populations is essential for healthcare and life sciences companies developing products and commercial strategies.
This report provides a comprehensive epidemiological assessment across the seven major markets (7MM), covering the US, France, Germany, Italy, Spain, the UK, and Japan.
You can use this report to:
- Quantify diagnosed and total prevalent overweight and obesity populations
- Understand epidemiological trends across the 7MM
- Assess patient populations by age, sex, and BMI class
- Evaluate key risk factors and associated comorbidities
- Support product design, pricing, and launch planning
- Identify patient segments with potential opportunities for obesity therapeutics

Key Insights in the Overweight and Obesity Epidemiology Landscape
The report highlights key epidemiological trends, including:
- Obesity is characterized by a BMI of 30kg/m² or more
- Obesity can be associated with metabolic dysfunction and chronic systemic inflammation
- Diabetes and cardiovascular disease are among the key comorbidities associated with obesity
- Obesogenic diets and sedentary lifestyles are important behavioural drivers
- Medical conditions, medications, and genetic factors may also contribute to weight gain
- Epidemiological trends are assessed across the US, France, Germany, Italy, Spain, the UK, and Japan
- Diagnosed and total prevalent cases are forecast over a 10-year period
- Populations are segmented by age, sex, and BMI class
- The analysis covers overweight classes I and II and obesity classes I, II, and III
Scope
What Will You Learn from This Overweight and Obesity Epidemiology Analysis Report?
This report provides insight into:
- Global and historical epidemiological trends for overweight and obesity
- Diagnosed and total prevalent cases across the 7MM
- Patient populations segmented by age from five years and older
- Sex-specific epidemiological trends
- Overweight classes I and II
- Obesity classes I, II, and III
- Risk factors associated with overweight and obesity
- Comorbidities associated with obesity
- Ten-year epidemiology forecasts
- Differences in epidemiological trends across the seven major markets
Who Should Buy This Overweight and Obesity Epidemiology Analysis Report?
This report may be valuable for:
- Pharmaceutical and biopharmaceutical companies
- Obesity and metabolic disease drug developers
- Clinical development teams
- Commercial strategy and market access teams
- Pricing and forecasting teams
- Sales and marketing teams
- Business development and licensing teams
- Epidemiology and market intelligence professionals
- Healthcare investors and consultants
How Companies Use This Overweight and Obesity Epidemiology Analysis
Life sciences and healthcare companies can use the report to:
- Quantify patient populations across key markets
- Support product design and development decisions
- Inform pricing and launch planning
- Identify high-opportunity age and sex segments
- Assess population differences by BMI class
- Understand the prevalence of relevant comorbidities
- Develop market-specific commercial strategies
- Prioritize sales and marketing efforts
- Support business planning and portfolio decisions
Reasons to Buy
Benchmark the Overweight and Obesity Epidemiology Landscape
This report enables stakeholders to benchmark:
- Diagnosed versus total prevalent cases
- Overweight and obesity populations across the 7MM
- Epidemiological trends by country
- Patient populations by age and sex
- Prevalence across BMI classes
- Obesity classes I, II, and III
- Associated comorbidities
- Historical versus forecast epidemiological trends
- Ten-year population forecasts across the covered markets
Built on GlobalData Epidemiology Intelligence
The epidemiology forecast is supported by data from peer-reviewed articles and population-based studies.
The methodology is applied consistently across the seven major markets, enabling meaningful comparison of diagnosed prevalent obesity cases and supporting analysis of population trends by age, sex, BMI class, and market.
Act Now to Identify Opportunities in Overweight and Obesity
As the overweight and obesity population evolves across major markets, understanding its size, demographic profile, BMI distribution, and associated comorbidities can help healthcare and life sciences companies make more informed decisions.
Use this report to quantify patient populations, identify high-opportunity segments, support product and pricing strategies, and plan market-specific launches and commercial activities.
Table of Contents
Table
Figures
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Obesity reports

